JAB wrote:
Hydroxychloroquine could have caused 17,000 deaths during COVID,
study finds
Former US President Donald Trump said: 'What do you have to lose?
Take
it.'
Nearly 17,000 people may have died after taking hydroxycholoroquine
during the first wave of COVID, according to a study by French
researchers.
....
....
Now, researchers have estimated that some 16,990 people in six
countries -- France, Belgium, Italy, Spain, Turkey and the U.S. --
may
have died as a result.
https://www.politico.eu/article/hydroxychloroquine-could-have-caused-17000-deaths-during-covid-study-finds/
Hydroxychloroquine,
an antimalarial drug, has been a subject of intense debate during the
COVID-19 pandemic due to its controversial use as a potential
treatment. While initial reports suggested it could be beneficial,
subsequent studies have cast doubt on its efficacy and raised concerns
about its safety.
**Study Findings:**
A study conducted by French researchers and published in the journal
_The Lancet_ estimated that hydroxychloroquine may have caused
approximately 17,000 deaths during the first wave of COVID-19 in six
countries: France, Belgium, Italy, Spain, Turkey, and the United
States. The study analyzed data from over 96,000 COVID-19 patients and
found that those who received hydroxychloroquine had a higher risk of
death compared to those who did not.
**Supporting Arguments:**
1. **Initial Promise:** Hydroxychloroquine has demonstrated antiviral
and anti-inflammatory properties in laboratory studies, suggesting its potential to combat COVID-19.
2. **Anecdotal Evidence:** Early reports from some physicians
indicated that hydroxychloroquine improved symptoms in COVID-19
patients, leading to initial optimism about its therapeutic
potential.
3. **Political Endorsement:** Former US President Donald Trump
publicly promoted hydroxychloroquine as a treatment for COVID-19,
further boosting its popularity and usage.
**Arguments Against:**
1. **Lack of Clinical Evidence:** Despite initial enthusiasm, rigorous
clinical trials have failed to provide consistent evidence supporting
the efficacy of hydroxychloroquine in treating COVID-19.
2. **Safety Concerns:** Hydroxychloroquine can cause various side
effects, including heart rhythm problems, liver damage, and kidney
failure. Its use in COVID-19 patients has been associated with an
increased risk of these adverse effects.
3. **Overprescription:** The widespread use of hydroxychloroquine,
often without proper medical supervision, raised concerns about
potential harm to patients, especially those with underlying health
conditions.
4. **Distraction from Other Treatments:** The focus on
hydroxychloroquine diverted resources and attention away from
developing and evaluating more promising treatments for COVID-19.
**Conclusion:**
The evidence regarding hydroxychloroquine's role in COVID-19 treatment
remains complex and evolving. While initial reports suggested
potential benefits, subsequent studies have raised significant doubts
about its efficacy and highlighted safety concerns. The overwhelming
consensus among medical experts is that hydroxychloroquine should not
be used as a treatment for COVID-19 outside of clinical trials. The
focus should be on therapies with proven effectiveness and a favorable
safety profile.
This is a response to the post seen at:
http://www.jlaforums.com/viewtopic.php?p=658448624#658448624
--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)